Mitochondrial dysfunction, oxidative stress, and major depressive disorder
Edward H Tobe University of Medicine and Dentistry of New Jersey/School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, and Cooper Medical School of Rowan University, Camden, NJ, USA Abstract: There is controversy about depression being...
Saved in:
Main Author: | Tobe EH |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/5f7ee33892484642a1e7317b53bde0dd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebellar dysregulation and heterogeneity of mood disorders
by: Tobe EH
Published: (2014) -
Desvenlafaxine in the treatment of major depressive disorder
by: Maria Teresa C Lourenco1, et al.
Published: (2009) -
Psychiatric comorbidities in patients with major depressive disorder
by: Thaipisuttikul P, et al.
Published: (2014) -
Comparative efficacy of escitalopram in the treatment of major depressive disorder
by: Mazen K Ali, et al.
Published: (2011) -
Augmentation treatment in major depressive disorder: focus on aripiprazole
by: J Craig Nelson, et al.
Published: (2008)